Evidence map›Paper›PMID 34630609›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Zhancheng Gu, Guoli Wei, Liangjun Zhu, Lingjun Zhu, Jing Hu, Qi Li, Guoxiang Cai, Hong Lu, Min Liu, Chen Chen and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Zhancheng GuThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210046, China.
Guoli WeiDepartment of Oncology, Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Nanjing 210046, China.
Liangjun ZhuDepartment of Medical Oncology, Jiangsu Cancer Hospital, Nanjing 210009, China.
Lingjun ZhuDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jing HuDepartment of Medical Oncology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
Qi LiDepartment of Oncology, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.
Guoxiang CaiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Hong LuDepartment of Chemotherapy, Changshu No. 1 People's Hospital, Chuzhou 239001, China.
Min LiuDepartment of Oncology, Suzhou Hospital of Traditional Chinese Medicine, Suzhou 215002, China.
Chen ChenDepartment of Oncology, Yancheng Hospital of Traditional Chinese Medicine, Yancheng 224005, China.
Yi JiDepartment of Oncology, Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine, Nanjing 210046, China.
Guochun LiSchool of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China.ORCID https://orcid.org/0000-0002-1680-130X
Jiege HuoThe Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210046, China.ORCID https://orcid.org/0000-0002-0463-134X
Nanjing University of Chinese Medicine · CNJiangsu Cancer Hospital · CNChangshu No.1 People's Hospital · CNFudan University Shanghai Cancer Center · CNNanjing Drum Tower Hospital · CNShanghai University of Traditional Chinese Medicine · CNSuzhou Traditional Chinese Medicine Hospital · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34630609
PMCPMC8494586
OpenAlexW3204615279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.